![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
20
Macfarlan Smith Limited Edinburgh Gb, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Veranova: A CDMO that manages complexity with confidence.
One of their significant offerings is Alfentanil hydrochloride hydrate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2010-008 - Rev 03
This Chemical Type CEP, issued on August 03, 2021, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1062 associated with this CEP further emphasizes